Ionis Pharmaceuticals (IONS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS)

IONS 76.28

-1.3%

Jan 16 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom jones who wrote (2132)	7/23/1998 8:05:00 AM
From: jackie	Read Replies (2) of 4676

If the antisense technology did not work, what did? If 'inactive' ingredients (preceding phrase is oxymoronic) are the cause of the improvements in these patients, why not just test with the 'inactive' ingredients? Wouldn't it be a lot easier and cheaper to just give injections of the 'inactive' ingredients? In fact, forget about the value of antisense technology, we have just seen the effectiveness of 'inactive' technology proven! So effective, it fooled the FDA panel. They thought antisense formulation was the source of the improvement in the test population. Regards, Jack

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next